With all due respect, G_F, I would've thought your projection for ENZC's PPS to 2020 YR-End, and into 2021 YR-End, would be a lot higher, given the information that's been emanating from and about the Company, especially as related to its holding the key for the BEST cure for Covid & HIV/AIDS (whose viruses are very similar, so believed their patents will be complementary or mutually beneficial), with 98% proven success for HIV/AIDS in Studies in 5 major universities, including Harvard & Duke. Plus BioClonetics is the ONLY all-natural-all-human mABS, meaning it is safer than any other cure out there for possible Covid & HIV/AIDS cure, with few if any side-effects.
Plus ENZC's formulary patent will block the virus from replicating itself, i.e., spreading/growing in the infected body, as well as from morphing into other strains or other viruses, thus ending the need for scientists to come up with a new vaccine every year to combat such new infectious diseases (Covid &/HIV/AIDS). This alone is HUGE!
Plus, in addition to providing a "cure" or "therapeutic" once a person has gotten infected with Covid/HIV-AIDS, ENZC is working on a "preventative", a type of pill (instead of a vaccine/injection) that people can take every month to protect themselves from contracting the diseases.
Plus, whereas Eli Lilly & Johnson and Johnson have dropped out of their clinical work on a cure for late-stage Covid, ENZC is working on this, (besides its other pharmaceutical goals), so that it would fill a much-needed "gap" which major pharmaceutical co's either cannot or will not do.
Plus, ENZC's patent solutions may be able to cure many other illneses, such as diptheria, rabies, MS, common cold, flus, and even some types of cancers.
Plus, ENZC already has a patented solution for HIV/AIDS that has been approved by Bulgarian Govt's equivalent to the US FDA, and its corresponding product is being sold succesfully throughout Europe already; since Bulgaria is one of the Countries that reciprocates with US FDA, it is believed that the process of such product being approved by FDA will be relatively short once applied for here in the U.S.
Plus, another superior factor is that ENZC' formulary patent for HIV/AIDS can be transported and stored at far lower-temperature levels, thus making it more cost-economical. THIS, in addition to the fact that ENZC's product can be manufactured more cheaply than any others (mainly because it is derived from taking a B-Cell from a previously-infected Covid patient, who has recovered, by the way~ thus eliminating the cost of having to involve stem-cells, embryos, a coctail of chemicals, and parts of mice, a process which would have to be highly regulated.)
I cannot help but think that with all these outstanding & unique features of ENZC, putting it in a class all its own, now that the Merger with BioClonetics is official, this new Company is headed toward becoming a big pharma itself relatively quickly. Some other public companies' PPS have risen very fast in the recent past, and in today's world where especially a cure for COVID & HIV/AIDS is desperately needed worldwide, I cannot but imagine ENZC's value will exponentially escalate (and as I believe you once said, "parabolically" increase), to the point it will be a rising star indeed very soon!, as ENZC's Owners whose lifelong pursuit in benefiting mankind will finally be realized.
Have you changed your stance in past few days? If so, perhaps you'd be kind enough to share your reasons why. Or perhaps, if I'm mistaken or have misunderstood, please forgive~
As always, thank you so much, G_F, for your faithful support & for all the great info you've supplied here over past several weeks re. ENZC!
News 
Market Data 
Discover 
AI
